NO985680L - Peptidderivater - Google Patents
PeptidderivaterInfo
- Publication number
- NO985680L NO985680L NO985680A NO985680A NO985680L NO 985680 L NO985680 L NO 985680L NO 985680 A NO985680 A NO 985680A NO 985680 A NO985680 A NO 985680A NO 985680 L NO985680 L NO 985680L
- Authority
- NO
- Norway
- Prior art keywords
- peptide
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/85—Reproductive organs or embryos
- Y10S530/851—Placenta; amniotic fluid
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Rehabilitation Therapy (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9611881.5A GB9611881D0 (en) | 1996-06-07 | 1996-06-07 | Peptide derivatives |
| GBGB9622890.3A GB9622890D0 (en) | 1996-11-02 | 1996-11-02 | Peptide compounds |
| PCT/GB1997/001491 WO1997046578A1 (fr) | 1996-06-07 | 1997-06-03 | Derives de peptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO985680D0 NO985680D0 (no) | 1998-12-04 |
| NO985680L true NO985680L (no) | 1999-02-04 |
Family
ID=26309459
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO985680A NO985680L (no) | 1996-06-07 | 1998-12-04 | Peptidderivater |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US6541453B2 (fr) |
| EP (1) | EP0914333B1 (fr) |
| JP (1) | JP2000512277A (fr) |
| KR (1) | KR100451522B1 (fr) |
| CN (1) | CN1130372C (fr) |
| AR (1) | AR008389A1 (fr) |
| AT (1) | ATE283278T1 (fr) |
| AU (1) | AU727757B2 (fr) |
| BR (1) | BR9709533A (fr) |
| CA (1) | CA2252417A1 (fr) |
| DE (1) | DE69731747T2 (fr) |
| HR (1) | HRP970308B1 (fr) |
| ID (1) | ID17440A (fr) |
| IL (1) | IL127332A0 (fr) |
| NO (1) | NO985680L (fr) |
| NZ (1) | NZ332347A (fr) |
| PL (1) | PL330348A1 (fr) |
| SK (1) | SK166798A3 (fr) |
| TR (1) | TR199802537T2 (fr) |
| TW (1) | TW474947B (fr) |
| WO (1) | WO1997046578A1 (fr) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9809021D0 (en) | 1998-04-29 | 1998-06-24 | Zeneca Ltd | Chemical process |
| JP2003512388A (ja) * | 1999-10-18 | 2003-04-02 | アクゾ・ノベル・エヌ・ベー | 免疫治療で使用される修飾ペプチドおよびペプチド模倣体 |
| JP2008188285A (ja) * | 2007-02-06 | 2008-08-21 | Bridgestone Corp | バックパッド及び車両用シート |
| RU2515615C2 (ru) * | 2008-09-18 | 2014-05-20 | Нортвестерн Юниверсити | Модуляторы нмда-рецептора и их применения |
| US8951968B2 (en) | 2009-10-05 | 2015-02-10 | Northwestern University | Methods of treating depression and other related diseases |
| KR101692275B1 (ko) | 2010-02-11 | 2017-01-04 | 노오쓰웨스턴 유니버시티 | 2차 구조 안정화된 nmda 수용체 조절제 및 그의 용도 |
| AU2011215704B2 (en) | 2010-02-11 | 2015-07-23 | Northwestern University | Secondary structure stabilized NMDA receptor modulators and uses thereof |
| BR112015018095A2 (pt) | 2013-01-29 | 2017-07-18 | Naurex Inc | moduladores de receptor nmda de espiro-lactama e usos dos mesmos |
| WO2014120784A1 (fr) | 2013-01-29 | 2014-08-07 | Naurex, Inc. | Modulateurs spirolactames d'un récepteur nmda et leurs utilisations |
| SG11201505934XA (en) | 2013-01-29 | 2015-09-29 | Naurex Inc | Spiro-lactam nmda receptor modulators and uses thereof |
| EP2951185B1 (fr) | 2013-01-29 | 2016-12-21 | Aptinyx Inc. | Modulateurs spirolactames d'un récepteur nmda et leurs utilisations |
| PT3514158T (pt) | 2013-01-29 | 2023-01-13 | Aptinyx Inc | Moduladores espirolactamas de um recetor nmda e as suas utilizações |
| CN109415372B (zh) | 2016-05-19 | 2021-01-15 | 阿普廷伊克斯股份有限公司 | 螺-内酰胺nmda受体调节剂及其用途 |
| WO2017201285A1 (fr) | 2016-05-19 | 2017-11-23 | Aptinyx Inc. | Modulateurs spirolactames des récepteurs nmda et leurs utilisations |
| CN109937204B (zh) | 2016-08-01 | 2022-11-25 | 阿普廷伊克斯股份有限公司 | 螺-内酰胺nmda受体调节剂及其用途 |
| CN109661398B (zh) | 2016-08-01 | 2022-07-05 | 阿普廷伊克斯股份有限公司 | 螺-内酰胺和二-螺-内酰胺nmda受体调节剂及其用途 |
| CA3031539C (fr) | 2016-08-01 | 2023-11-28 | Aptinyx Inc. | Modulateurs spirolactames des recepteurs nmda et leurs utilisations |
| KR102503590B1 (ko) | 2016-08-01 | 2023-02-24 | 앱티닉스 인크. | 스피로-락탐 nmda 수용체 조정제 및 그의 용도 |
| PE20190501A1 (es) | 2016-08-01 | 2019-04-10 | Aptinyx Inc | Moduladores nmda espiro-lactam y metodos de uso de los mismos |
| US11578072B2 (en) | 2018-01-31 | 2023-02-14 | Aptinyx Inc. | Spiro-lactam NMDA receptor modulators and uses thereof |
| CN109115899A (zh) * | 2018-06-19 | 2019-01-01 | 南京肽业生物科技有限公司 | 一种Fmoc氨基酸的分析方法 |
| US12012413B2 (en) | 2019-11-11 | 2024-06-18 | Tenacia Biotechnology (Hong Kong) Co., Limited | Methods of treating painful diabetic peripheral neuropathy |
| EP4141110A4 (fr) | 2020-04-24 | 2025-04-09 | Sf Biotech Laboratuvar Danismanlik Anonim Sirketi | Procédé de production de particules de bactériophages de la famille levivirus |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4254107A (en) | 1979-11-27 | 1981-03-03 | Merck & Co., Inc. | Long-lasting agonists of enkephalin |
| US4301151A (en) | 1979-11-27 | 1981-11-17 | Merck & Co., Inc. | Long-lasting agonists of enkephalin |
| US4474778A (en) | 1983-11-09 | 1984-10-02 | E. R. Squibb & Sons, Inc. | Lactam containing compounds, their pharmaceutical compositions and method of use |
| US4680283A (en) | 1984-09-26 | 1987-07-14 | Merck & Co., Inc. | Analogs of substance P and eledoisin |
| DE3711335A1 (de) | 1987-04-03 | 1988-10-20 | Merck Patent Gmbh | Aminosaeurederivate |
| US5331089A (en) | 1988-03-25 | 1994-07-19 | Merck Sharpe & Dohme, Ltd. | Peptides useful as tachykinin agonists |
| EP0360390A1 (fr) | 1988-07-25 | 1990-03-28 | Glaxo Group Limited | Dérivés de spirolactames |
| WO1990003399A1 (fr) * | 1988-09-30 | 1990-04-05 | Australian Commercial Research & Development Limited | Proteines de transport d'acides amines, analogues d'acides amines, appareil d'analyse et utilisations de ces elements pour le traitement et le diagnostic du cancer |
| US5223485A (en) | 1989-01-31 | 1993-06-29 | Abbott Laboratories | Anaphylatoxin-receptor ligands |
| WO1992002543A1 (fr) | 1990-08-01 | 1992-02-20 | Cytel Corporation | Nouveaux peptides immunosuppresseurs |
| DE4034829A1 (de) | 1990-11-02 | 1992-05-07 | Merck Patent Gmbh | Cyclopeptide |
| AU2468392A (en) | 1991-08-29 | 1993-04-05 | Cytel Corporation | Novel immunosuppressants |
| DK0644197T3 (da) | 1993-06-04 | 1999-06-07 | Vertex Pharma | Peptidphosphinyloxymethylketoner som inhibitorer af interleukin-1beta-konverterende enzymer |
| AU698962B2 (en) | 1993-09-14 | 1998-11-12 | Epimmune, Inc. | Alteration of immune response using pan DR-binding peptides |
| AU2238395A (en) * | 1994-04-01 | 1995-10-23 | Immulogic Pharmaceutical Corporation | Haptenated peptides and uses thereof |
| CA2215695C (fr) | 1995-03-24 | 2003-09-16 | Molecumetics, Ltd | Imitateurs de feuillets .beta. et leur utilisation en tant qu'inhibiteurs de protease |
| US5840835A (en) | 1995-10-30 | 1998-11-24 | Merck & Co., Inc. | Inhibitors of peptide binding to MHC class II proteins |
| US5817757A (en) | 1995-10-30 | 1998-10-06 | Merck & Co., Inc. | Inhibitors of peptide binding to MHO class II proteins |
| US5719296A (en) | 1995-10-30 | 1998-02-17 | Merck & Co., Inc. | Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins |
| AU7604196A (en) | 1995-10-30 | 1997-05-22 | Merck & Co., Inc. | Novel inhibitors of peptide binding to mhc class ii proteins |
| GB9702377D0 (en) | 1996-02-23 | 1997-03-26 | Zeneca Ltd | Peptide derivatives |
| GB9621836D0 (en) | 1996-10-19 | 1996-12-11 | Zeneca Ltd | Peptide compounds |
| GB9625865D0 (en) | 1996-12-12 | 1997-01-29 | Zeneca Ltd | Peptides |
-
1997
- 1997-06-03 JP JP10500312A patent/JP2000512277A/ja not_active Ceased
- 1997-06-03 SK SK1667-98A patent/SK166798A3/sk unknown
- 1997-06-03 IL IL12733297A patent/IL127332A0/xx unknown
- 1997-06-03 AU AU29720/97A patent/AU727757B2/en not_active Ceased
- 1997-06-03 AT AT97924156T patent/ATE283278T1/de not_active IP Right Cessation
- 1997-06-03 US US09/202,077 patent/US6541453B2/en not_active Expired - Fee Related
- 1997-06-03 WO PCT/GB1997/001491 patent/WO1997046578A1/fr not_active Ceased
- 1997-06-03 CN CN97195216A patent/CN1130372C/zh not_active Expired - Fee Related
- 1997-06-03 DE DE69731747T patent/DE69731747T2/de not_active Expired - Fee Related
- 1997-06-03 CA CA002252417A patent/CA2252417A1/fr not_active Abandoned
- 1997-06-03 NZ NZ332347A patent/NZ332347A/xx unknown
- 1997-06-03 BR BR9709533A patent/BR9709533A/pt not_active Application Discontinuation
- 1997-06-03 KR KR10-1998-0710049A patent/KR100451522B1/ko not_active Expired - Fee Related
- 1997-06-03 EP EP97924156A patent/EP0914333B1/fr not_active Expired - Lifetime
- 1997-06-03 PL PL97330348A patent/PL330348A1/xx unknown
- 1997-06-03 TR TR1998/02537T patent/TR199802537T2/xx unknown
- 1997-06-04 HR HR970308A patent/HRP970308B1/xx not_active IP Right Cessation
- 1997-06-06 AR ARP970102498A patent/AR008389A1/es unknown
- 1997-06-06 ID IDP971947A patent/ID17440A/id unknown
- 1997-06-06 TW TW086107849A patent/TW474947B/zh not_active IP Right Cessation
-
1998
- 1998-12-04 NO NO985680A patent/NO985680L/no not_active Application Discontinuation
-
2002
- 2002-12-16 US US10/319,512 patent/US20030195158A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL127332A0 (en) | 1999-09-22 |
| NO985680D0 (no) | 1998-12-04 |
| US20030195158A1 (en) | 2003-10-16 |
| HRP970308B1 (en) | 2002-04-30 |
| ATE283278T1 (de) | 2004-12-15 |
| CN1130372C (zh) | 2003-12-10 |
| AU2972097A (en) | 1998-01-05 |
| KR100451522B1 (ko) | 2004-12-08 |
| PL330348A1 (en) | 1999-05-10 |
| CN1221424A (zh) | 1999-06-30 |
| EP0914333A1 (fr) | 1999-05-12 |
| BR9709533A (pt) | 1999-08-10 |
| KR20000016465A (ko) | 2000-03-25 |
| JP2000512277A (ja) | 2000-09-19 |
| DE69731747D1 (de) | 2004-12-30 |
| DE69731747T2 (de) | 2006-02-02 |
| AU727757B2 (en) | 2000-12-21 |
| CA2252417A1 (fr) | 1997-12-11 |
| TW474947B (en) | 2002-02-01 |
| US20020103335A1 (en) | 2002-08-01 |
| ID17440A (id) | 1997-12-24 |
| WO1997046578A1 (fr) | 1997-12-11 |
| US6541453B2 (en) | 2003-04-01 |
| NZ332347A (en) | 2000-05-26 |
| AR008389A1 (es) | 2000-01-19 |
| TR199802537T2 (xx) | 1999-03-22 |
| SK166798A3 (en) | 1999-07-12 |
| EP0914333B1 (fr) | 2004-11-24 |
| HRP970308A2 (en) | 1998-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI961350A7 (fi) | Hapteenimerkityt peptidit | |
| FI965225L (fi) | Uusia peptidejä | |
| ATE208395T1 (de) | Thiophenopyrimidine | |
| ATE262512T1 (de) | Arylalkanoylpyridazine | |
| NO985680D0 (no) | Peptidderivater | |
| ATE208773T1 (de) | Chinoxalindione | |
| NO983849D0 (no) | Peptidderivater | |
| ATE353652T1 (de) | Östroprogestatives antikonzeptionsmittel | |
| BR9508433A (pt) | Peptídeos | |
| DK0832553T3 (da) | Mejetærsker | |
| FI964363L (fi) | Peptidejä | |
| TR199701666A3 (tr) | Sismanliga karsi proteinler | |
| BR9606756A (pt) | Peptídeo | |
| DE59712867D1 (de) | Umrichterschweissanordnung | |
| NO981052D0 (no) | Peptidderivater | |
| ATE235511T1 (de) | Vielfältig verzweigte peptidkonstruktionen | |
| NO981051D0 (no) | Peptidderivater | |
| DK1017798T3 (da) | Lunasinpeptider | |
| NO20000976D0 (no) | Peptider | |
| SE9504467D0 (sv) | Peptide | |
| BR1100812A (pt) | Peptìdeo | |
| ID17224A (id) | Sediaan | |
| BR7601548U (pt) | Tomadamax | |
| BR7602320U (pt) | Supedânea | |
| BR7600429U (pt) | Hidrolax |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |